Medical Device Investing Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
Medical Device Investing Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
Medical Device Investing Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
Medical Device Investing Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
Medical Device Investing New survey: 1 in 3 women have not talked to their doctor about heart health, the #1 killer of women
Medical Device Investing Medtronic Affera pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
Medical Device Investing Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo robotic-assisted surgery system
Medical Device Investing Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead and announces investigational clinical study results
Medical Device Investing Medtronic advances Abbott CGM partnership with FDA submission of interoperable insulin pump
Medical Device Investing Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
Medical Device Investing Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
Medical Device Investing Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations
Medical Device Investing Medtronic Evolut TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
Precious Metals & Critical Minerals Hybrid Investor Conference: Presentations Now Available for Online Viewing
